The global Human Augmentation in Healthcare market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Human Augmentation in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Augmentation in Healthcare.
Report Scope
The Human Augmentation in Healthcare market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Augmentation in Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Augmentation in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
20 Knots Plus Ltd (20KTS+)
Abbott Laboratories
AbbVie Inc.
Abiomed
Asahi Kasei Kuraray Medical Co. Ltd.
Baxter International
Bionic Power
Boston Scientific Corporation
Cochlear Ltd.
Edwards Lifesciences Corporation
Ekso Bionics Holdings Inc.
ExoAtlet
LivaNova PLC
Lockheed Martin Corporation
Medtronic plc
Orthofix Holdings Inc.
Ossur Corporate
Otto Bock HealthCare GmBH
RB3D
Retina Implant AG
Sarcos Corporation
Sonova Holding AG
Spring Active
SRI International
SynCardia Systems LLC
Zimmer Biomet Holdings
Segment by Type
Power Prosthetics
Artificial Organ
Exoskeletons
Others
Segment by Application
General Medical
Military Application
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Augmentation in Healthcare companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Human Augmentation in Healthcare 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Power Prosthetics
1.2.3 Artificial Organ
1.2.4 Exoskeletons
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Human Augmentation in Healthcare 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Medical
1.3.3 Military Application
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Augmentation in Healthcare 麻豆原创 Perspective (2019-2030)
2.2 Human Augmentation in Healthcare Growth Trends by Region
2.2.1 Global Human Augmentation in Healthcare 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Augmentation in Healthcare Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Human Augmentation in Healthcare Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Human Augmentation in Healthcare 麻豆原创 Dynamics
2.3.1 Human Augmentation in Healthcare Industry Trends
2.3.2 Human Augmentation in Healthcare 麻豆原创 Drivers
2.3.3 Human Augmentation in Healthcare 麻豆原创 Challenges
2.3.4 Human Augmentation in Healthcare 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Augmentation in Healthcare Players by Revenue
3.1.1 Global Top Human Augmentation in Healthcare Players by Revenue (2019-2024)
3.1.2 Global Human Augmentation in Healthcare Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Human Augmentation in Healthcare 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Augmentation in Healthcare Revenue
3.4 Global Human Augmentation in Healthcare 麻豆原创 Concentration Ratio
3.4.1 Global Human Augmentation in Healthcare 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Augmentation in Healthcare Revenue in 2023
3.5 Human Augmentation in Healthcare Key Players Head office and Area Served
3.6 Key Players Human Augmentation in Healthcare Product Solution and Service
3.7 Date of Enter into Human Augmentation in Healthcare 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Augmentation in Healthcare Breakdown Data by Type
4.1 Global Human Augmentation in Healthcare Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Human Augmentation in Healthcare Forecasted 麻豆原创 Size by Type (2025-2030)
5 Human Augmentation in Healthcare Breakdown Data by Application
5.1 Global Human Augmentation in Healthcare Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Human Augmentation in Healthcare Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Human Augmentation in Healthcare 麻豆原创 Size (2019-2030)
6.2 North America Human Augmentation in Healthcare 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Augmentation in Healthcare 麻豆原创 Size by Country (2019-2024)
6.4 North America Human Augmentation in Healthcare 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Augmentation in Healthcare 麻豆原创 Size (2019-2030)
7.2 Europe Human Augmentation in Healthcare 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Augmentation in Healthcare 麻豆原创 Size by Country (2019-2024)
7.4 Europe Human Augmentation in Healthcare 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Augmentation in Healthcare 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Human Augmentation in Healthcare 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Augmentation in Healthcare 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Human Augmentation in Healthcare 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Augmentation in Healthcare 麻豆原创 Size (2019-2030)
9.2 Latin America Human Augmentation in Healthcare 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Augmentation in Healthcare 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Human Augmentation in Healthcare 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Augmentation in Healthcare 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Human Augmentation in Healthcare 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Augmentation in Healthcare 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Human Augmentation in Healthcare 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 20 Knots Plus Ltd (20KTS+)
11.1.1 20 Knots Plus Ltd (20KTS+) Company Detail
11.1.2 20 Knots Plus Ltd (20KTS+) Business Overview
11.1.3 20 Knots Plus Ltd (20KTS+) Human Augmentation in Healthcare Introduction
11.1.4 20 Knots Plus Ltd (20KTS+) Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.1.5 20 Knots Plus Ltd (20KTS+) Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Human Augmentation in Healthcare Introduction
11.2.4 Abbott Laboratories Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Detail
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Human Augmentation in Healthcare Introduction
11.3.4 AbbVie Inc. Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.3.5 AbbVie Inc. Recent Development
11.4 Abiomed
11.4.1 Abiomed Company Detail
11.4.2 Abiomed Business Overview
11.4.3 Abiomed Human Augmentation in Healthcare Introduction
11.4.4 Abiomed Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.4.5 Abiomed Recent Development
11.5 Asahi Kasei Kuraray Medical Co. Ltd.
11.5.1 Asahi Kasei Kuraray Medical Co. Ltd. Company Detail
11.5.2 Asahi Kasei Kuraray Medical Co. Ltd. Business Overview
11.5.3 Asahi Kasei Kuraray Medical Co. Ltd. Human Augmentation in Healthcare Introduction
11.5.4 Asahi Kasei Kuraray Medical Co. Ltd. Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.5.5 Asahi Kasei Kuraray Medical Co. Ltd. Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Detail
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Human Augmentation in Healthcare Introduction
11.6.4 Baxter International Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.6.5 Baxter International Recent Development
11.7 Bionic Power
11.7.1 Bionic Power Company Detail
11.7.2 Bionic Power Business Overview
11.7.3 Bionic Power Human Augmentation in Healthcare Introduction
11.7.4 Bionic Power Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.7.5 Bionic Power Recent Development
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Company Detail
11.8.2 Boston Scientific Corporation Business Overview
11.8.3 Boston Scientific Corporation Human Augmentation in Healthcare Introduction
11.8.4 Boston Scientific Corporation Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.8.5 Boston Scientific Corporation Recent Development
11.9 Cochlear Ltd.
11.9.1 Cochlear Ltd. Company Detail
11.9.2 Cochlear Ltd. Business Overview
11.9.3 Cochlear Ltd. Human Augmentation in Healthcare Introduction
11.9.4 Cochlear Ltd. Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.9.5 Cochlear Ltd. Recent Development
11.10 Edwards Lifesciences Corporation
11.10.1 Edwards Lifesciences Corporation Company Detail
11.10.2 Edwards Lifesciences Corporation Business Overview
11.10.3 Edwards Lifesciences Corporation Human Augmentation in Healthcare Introduction
11.10.4 Edwards Lifesciences Corporation Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.10.5 Edwards Lifesciences Corporation Recent Development
11.11 Ekso Bionics Holdings Inc.
11.11.1 Ekso Bionics Holdings Inc. Company Detail
11.11.2 Ekso Bionics Holdings Inc. Business Overview
11.11.3 Ekso Bionics Holdings Inc. Human Augmentation in Healthcare Introduction
11.11.4 Ekso Bionics Holdings Inc. Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.11.5 Ekso Bionics Holdings Inc. Recent Development
11.12 ExoAtlet
11.12.1 ExoAtlet Company Detail
11.12.2 ExoAtlet Business Overview
11.12.3 ExoAtlet Human Augmentation in Healthcare Introduction
11.12.4 ExoAtlet Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.12.5 ExoAtlet Recent Development
11.13 LivaNova PLC
11.13.1 LivaNova PLC Company Detail
11.13.2 LivaNova PLC Business Overview
11.13.3 LivaNova PLC Human Augmentation in Healthcare Introduction
11.13.4 LivaNova PLC Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.13.5 LivaNova PLC Recent Development
11.14 Lockheed Martin Corporation
11.14.1 Lockheed Martin Corporation Company Detail
11.14.2 Lockheed Martin Corporation Business Overview
11.14.3 Lockheed Martin Corporation Human Augmentation in Healthcare Introduction
11.14.4 Lockheed Martin Corporation Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.14.5 Lockheed Martin Corporation Recent Development
11.15 Medtronic plc
11.15.1 Medtronic plc Company Detail
11.15.2 Medtronic plc Business Overview
11.15.3 Medtronic plc Human Augmentation in Healthcare Introduction
11.15.4 Medtronic plc Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.15.5 Medtronic plc Recent Development
11.16 Orthofix Holdings Inc.
11.16.1 Orthofix Holdings Inc. Company Detail
11.16.2 Orthofix Holdings Inc. Business Overview
11.16.3 Orthofix Holdings Inc. Human Augmentation in Healthcare Introduction
11.16.4 Orthofix Holdings Inc. Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.16.5 Orthofix Holdings Inc. Recent Development
11.17 Ossur Corporate
11.17.1 Ossur Corporate Company Detail
11.17.2 Ossur Corporate Business Overview
11.17.3 Ossur Corporate Human Augmentation in Healthcare Introduction
11.17.4 Ossur Corporate Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.17.5 Ossur Corporate Recent Development
11.18 Otto Bock HealthCare GmBH
11.18.1 Otto Bock HealthCare GmBH Company Detail
11.18.2 Otto Bock HealthCare GmBH Business Overview
11.18.3 Otto Bock HealthCare GmBH Human Augmentation in Healthcare Introduction
11.18.4 Otto Bock HealthCare GmBH Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.18.5 Otto Bock HealthCare GmBH Recent Development
11.19 RB3D
11.19.1 RB3D Company Detail
11.19.2 RB3D Business Overview
11.19.3 RB3D Human Augmentation in Healthcare Introduction
11.19.4 RB3D Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.19.5 RB3D Recent Development
11.20 Retina Implant AG
11.20.1 Retina Implant AG Company Detail
11.20.2 Retina Implant AG Business Overview
11.20.3 Retina Implant AG Human Augmentation in Healthcare Introduction
11.20.4 Retina Implant AG Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.20.5 Retina Implant AG Recent Development
11.21 Sarcos Corporation
11.21.1 Sarcos Corporation Company Detail
11.21.2 Sarcos Corporation Business Overview
11.21.3 Sarcos Corporation Human Augmentation in Healthcare Introduction
11.21.4 Sarcos Corporation Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.21.5 Sarcos Corporation Recent Development
11.22 Sonova Holding AG
11.22.1 Sonova Holding AG Company Detail
11.22.2 Sonova Holding AG Business Overview
11.22.3 Sonova Holding AG Human Augmentation in Healthcare Introduction
11.22.4 Sonova Holding AG Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.22.5 Sonova Holding AG Recent Development
11.23 Spring Active
11.23.1 Spring Active Company Detail
11.23.2 Spring Active Business Overview
11.23.3 Spring Active Human Augmentation in Healthcare Introduction
11.23.4 Spring Active Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.23.5 Spring Active Recent Development
11.24 SRI International
11.24.1 SRI International Company Detail
11.24.2 SRI International Business Overview
11.24.3 SRI International Human Augmentation in Healthcare Introduction
11.24.4 SRI International Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.24.5 SRI International Recent Development
11.25 SynCardia Systems LLC
11.25.1 SynCardia Systems LLC Company Detail
11.25.2 SynCardia Systems LLC Business Overview
11.25.3 SynCardia Systems LLC Human Augmentation in Healthcare Introduction
11.25.4 SynCardia Systems LLC Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.25.5 SynCardia Systems LLC Recent Development
11.26 Zimmer Biomet Holdings
11.26.1 Zimmer Biomet Holdings Company Detail
11.26.2 Zimmer Biomet Holdings Business Overview
11.26.3 Zimmer Biomet Holdings Human Augmentation in Healthcare Introduction
11.26.4 Zimmer Biomet Holdings Revenue in Human Augmentation in Healthcare Business (2019-2024)
11.26.5 Zimmer Biomet Holdings Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
20 Knots Plus Ltd (20KTS+)
Abbott Laboratories
AbbVie Inc.
Abiomed
Asahi Kasei Kuraray Medical Co. Ltd.
Baxter International
Bionic Power
Boston Scientific Corporation
Cochlear Ltd.
Edwards Lifesciences Corporation
Ekso Bionics Holdings Inc.
ExoAtlet
LivaNova PLC
Lockheed Martin Corporation
Medtronic plc
Orthofix Holdings Inc.
Ossur Corporate
Otto Bock HealthCare GmBH
RB3D
Retina Implant AG
Sarcos Corporation
Sonova Holding AG
Spring Active
SRI International
SynCardia Systems LLC
Zimmer Biomet Holdings
听
听
*If Applicable.